According to Zhitong Finance App, Beautiful Garden Healthcare (02373.HK) issued an announcement. On August 5, 2026, the buyer (Nariel Medical Devices and Narrell Health Management, each a non-wholly-owned subsidiary of the company) and the seller (Guangzhou Beimin Enterprise Management Co., Ltd.) signed a 2026 equity transfer agreement. According to the 2026 equity transfer agreement (which includes), the seller conditionally agreed to the sale, and the buyer conditionally agreed to acquire the target business (including 100% of the shares of Hangzhou Narell Health Technology Co., Ltd. and Hangzhou Xiaoshan Ariel Medical & Aesthetic Clinic Co., Ltd.), at a total cost of RMB 10 million. After the acquisition is completed in 2026, the company will own 90% of the shares in the target companies, which will become non-wholly-owned subsidiaries of the company.

According to Zhitong Finance App, Beautiful Garden Healthcare (02373.HK) issued an announcement. On August 5, 2026, the buyer (Nariel Medical Devices and Narrell Health Management, each a non-wholly-owned subsidiary of the company) and the seller (Guangzhou Beimin Enterprise Management Co., Ltd.) signed a 2026 equity transfer agreement. According to the 2026 equity transfer agreement (which includes), the seller conditionally agreed to the sale, and the buyer conditionally agreed to acquire the target business (including 100% of the shares of Hangzhou Narell Health Technology Co., Ltd. and Hangzhou Xiaoshan Ariel Medical Beauty Clinic Co., Ltd.), at a total cost of RMB 10 million. After the acquisition is completed in 2026, the company will own 90% of the shares in the target companies, which will become non-wholly-owned subsidiaries of the company.